1326 ET - Hinge Health's expansion beyond physical therapy can further propel the company's growth for years to come, Morgan Stanley analysts say in a research note. The digital-health company, which for more than a decade has been focused on delivering musculoskeletal care, earlier this year launched a migraine-care program. The new offering built on Hinge's existing technology, enables it to address additional care needs within its installed client base, the analysts say. Further product innovations could continually enhance the company's flywheel, especially if they continue to roll out with similarly high margins and returns on investment: "One of the key debates for the stock is durability of growth, and we remain buyers on the view that ongoing momentum in the core MSK business and ramp of new offerings will surprise to the upside."